BGI

B Group Inc Portfolio holdings

AUM $116M
This Quarter Est. Return
1 Year Est. Return
–
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$115M
AUM Growth
+$9.5M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
19
New
Increased
Reduced
Closed

Top Buys

1
+$1.69M
2
+$1.44M
3
+$1.43M
4
BNTX icon
BioNTech
BNTX
+$1.05M
5
PRAX icon
Praxis Precision Medicines
PRAX
+$720K

Top Sells

1
+$6.68M
2
+$708K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADMA icon
1
ADMA Biologics
ADMA
$3.43B
$46M 39.39%
2,317,542
+30,000
INSM icon
2
Insmed
INSM
$35B
$20M 17.16%
262,500
-87,500
ZLAB icon
3
Zai Lab
ZLAB
$3.15B
$14.5M 12.38%
400,000
AKRO icon
4
Akero Therapeutics
AKRO
$4.32B
$9.82M 8.41%
242,500
-17,500
IOVA icon
5
Iovance Biotherapeutics
IOVA
$789M
$5M 4.28%
1,500,000
+508,000
CLLS
6
Cellectis
CLLS
$399M
$4.04M 3.46%
3,256,501
+175,000
AURA icon
7
Aura Biosciences
AURA
$352M
$2.77M 2.37%
472,576
SGHT icon
8
Sight Sciences
SGHT
$246M
$2M 1.71%
833,600
+204,230
ASMB icon
9
Assembly Biosciences
ASMB
$226M
$1.91M 1.64%
200,000
+149,349
TSHA icon
10
Taysha Gene Therapies
TSHA
$1.29B
$1.75M 1.5%
1,255,556
+290,000
RARE icon
11
Ultragenyx Pharmaceutical
RARE
$3.14B
$1.72M 1.47%
47,500
+39,904
BNTX icon
12
BioNTech
BNTX
$25.3B
$1.37M 1.17%
15,000
+11,500
SYRE icon
13
Spyre Therapeutics
SYRE
$1.74B
$1.13M 0.97%
70,000
+20,000
APGE icon
14
Apogee Therapeutics
APGE
$3.73B
$1.12M 0.96%
30,000
+15,000
PRAX icon
15
Praxis Precision Medicines
PRAX
$4B
$720K 0.62%
+19,000
ETNB icon
16
89bio
ETNB
$2.19B
$695K 0.6%
+95,623
ORKA
17
Oruka Therapeutics
ORKA
$1.33B
$597K 0.51%
58,215
+38,215
CRVS icon
18
Corvus Pharmaceuticals
CRVS
$525M
– –
0
QQQ icon
19
Invesco QQQ Trust
QQQ
$384B
– –
0